These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

724 related articles for article (PubMed ID: 26275624)

  • 21. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiparametric MR Imaging with High-Resolution Dynamic Contrast-enhanced and Diffusion-weighted Imaging at 7 T Improves the Assessment of Breast Tumors: A Feasibility Study.
    Pinker K; Baltzer P; Bogner W; Leithner D; Trattnig S; Zaric O; Dubsky P; Bago-Horvath Z; Rudas M; Gruber S; Weber M; Helbich TH
    Radiology; 2015 Aug; 276(2):360-70. PubMed ID: 25751227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravoxel Incoherent Motion Diffusion-Weighted Imaging Versus Dynamic Contrast-Enhanced Magnetic Resonance Imaging: Comparison of the Diagnostic Performance of Perfusion-Related Parameters in Breast.
    Jiang L; Lu X; Hua B; Gao J; Zheng D; Zhou Y
    J Comput Assist Tomogr; 2018; 42(1):6-11. PubMed ID: 28786902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of diffusion weighted imaging and magnetic resonance spectroscopy in breast cancer patients with indeterminate dynamic contrast enhanced magnetic resonance imaging findings.
    Sharma U; Agarwal K; Hari S; Mathur SR; Seenu V; Parshad R; Jagannathan NR
    Magn Reson Imaging; 2019 Sep; 61():66-72. PubMed ID: 31128225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accuracy of multiparametric MRI in distinguishing the breast malignant lesions from benign lesions: a meta-analysis.
    Zhu CR; Chen KY; Li P; Xia ZY; Wang B
    Acta Radiol; 2021 Oct; 62(10):1290-1297. PubMed ID: 33059458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How to manage type 2 curve dilemma in dynamic contrast-enhanced magnetic resonance imaging of the breast: diffusion-weighted imaging or early phase enhancement kinetics?
    Ulu Öztürk F; Tezcan Ş; Uslu N
    Acta Radiol; 2024 Apr; 65(4):341-349. PubMed ID: 38193154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive value of T2-weighted imaging and dynamic contrast-enhanced MRI for assessing cervical invasion in patients with endometrial cancer: a meta-analysis.
    Bi Q; Chen Y; Chen J; Zhang H; Lei Y; Yang J; Zhang Y; Bi G
    Clin Imaging; 2021 Oct; 78():206-213. PubMed ID: 34049140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative DWI implemented after DCE-MRI yields increased specificity for BI-RADS 3 and 4 breast lesions.
    Dijkstra H; Dorrius MD; Wielema M; Pijnappel RM; Oudkerk M; Sijens PE
    J Magn Reson Imaging; 2016 Dec; 44(6):1642-1649. PubMed ID: 27273694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Qualitative characterization of breast tumors with diffusion-weighted imaging has comparable accuracy to quantitative analysis.
    Kul S; Metin Y; Bekircavusoglu S; Kul M
    Clin Imaging; 2021 Sep; 77():17-24. PubMed ID: 33639496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic accuracy of magnetic resonance imaging techniques for parotid tumors, a systematic review and meta-analysis.
    Liang YY; Xu F; Guo Y; Wang J
    Clin Imaging; 2018; 52():36-43. PubMed ID: 29908348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphoma and inflammation in the orbit: Diagnostic performance with diffusion-weighted imaging and dynamic contrast-enhanced MRI.
    Sun B; Song L; Wang X; Li J; Xian J; Wang F; Tan P
    J Magn Reson Imaging; 2017 May; 45(5):1438-1445. PubMed ID: 27649521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the prostate imaging reporting and data system for the detection of prostate cancer by the results of targeted biopsy of the prostate.
    Baur AD; Maxeiner A; Franiel T; Kilic E; Huppertz A; Schwenke C; Hamm B; Durmus T
    Invest Radiol; 2014 Jun; 49(6):411-20. PubMed ID: 24598440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overall diagnostic accuracy of different MR imaging sequences for detection of dysplastic nodules: a systematic review and meta-analysis.
    Xiong J; Luo J; Bian J; Wu J
    Eur Radiol; 2022 Feb; 32(2):1285-1296. PubMed ID: 34357448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The value of breath-hold diffusion-weighted imaging in small hepatocellular carcinoma lesion (Xu PJ; Yan FH; Wang JH; Lin J; Ji Y; Chen CZ; Shen JZ; Li RC
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(9):592-6. PubMed ID: 19595157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Breast Cancer Morphology Using Diffusion-Weighted and Dynamic Contrast-Enhanced MRI: Intermethod and Interobserver Agreement.
    Radovic N; Ivanac G; Divjak E; Biondic I; Bulum A; Brkljacic B
    J Magn Reson Imaging; 2019 May; 49(5):1381-1390. PubMed ID: 30325549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer.
    Vilanova JC; Barceló-Vidal C; Comet J; Boada M; Barceló J; Ferrer J; Albanell J
    AJR Am J Roentgenol; 2011 Jun; 196(6):W715-22. PubMed ID: 21606259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate cancer: diffusion-weighted imaging versus dynamic-contrast enhanced imaging for tumor localization-a meta-analysis.
    Haghighi M; Shah S; Taneja SS; Rosenkrantz AB
    J Comput Assist Tomogr; 2013; 37(6):980-8. PubMed ID: 24270122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Preliminary study of combining T2-weighted imaging, diffusion weighted imaging and dynamic contrast enhanced-magnetic resonance imaging for diagnosing prostatic central gland cancer].
    Li P; Yang W; Chen Z; Guo Y; Cai L; Du Y; Li Y
    Zhonghua Yi Xue Za Zhi; 2014 Aug; 94(31):2448-51. PubMed ID: 25400054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment Response Evaluation of Breast Cancer after Neoadjuvant Chemotherapy and Usefulness of the Imaging Parameters of MRI and PET/CT.
    An YY; Kim SH; Kang BJ; Lee AW
    J Korean Med Sci; 2015 Jun; 30(6):808-15. PubMed ID: 26028936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diffusion-weighted imaging in monitoring the pathological response to neoadjuvant chemotherapy in patients with breast cancer: a meta-analysis.
    Gao W; Guo N; Dong T
    World J Surg Oncol; 2018 Jul; 16(1):145. PubMed ID: 30021656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.